The Biotech Growth Trust PLC Cash Flow Quality Index
The Biotech Growth Trust PLC cash flow quality index. The Biotech Growth Trust PLC (BIOG) has a Cash Flow Quality Index of -0.04x as of September 2025. Operating cash flow of GBX-2.52 Million is below net income of GBX69.42 Million, suggesting accrual-heavy earnings not yet converted to cash. See BIOG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of The Biotech Growth Trust PLC (2012–2024)
Cash flow quality index of The Biotech Growth Trust PLC from 2012 to 2024. Historical Cash Flow Quality Index for The Biotech Growth Trust PLC across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore BIOG cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
The Biotech Growth Trust PLC Cash Flow Quality Index by Year (2012–2024)
The Biotech Growth Trust PLC cash flow quality index by year from 2012 to 2024. Year-by-year earnings quality comparison for The Biotech Growth Trust PLC. For the full cash flow conversion analysis, see BIOG cash flow conversion.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.06x | GBX-4.24 Million | GBX74.60 Million | ▼ -100.9% |
| 2021 | -0.03x | GBX-5.67 Million | GBX200.56 Million | ▲ +54.1% |
| 2020 | -0.06x | GBX-3.77 Million | GBX61.09 Million | ▲ +70.2% |
| 2019 | -0.21x | GBX-4.40 Million | GBX21.29 Million | ▼ -285.5% |
| 2017 | -0.05x | GBX-5.29 Million | GBX98.58 Million | ▼ -1735.0% |
| 2015 | 0.00x | GBX703.00K | GBX214.39 Million | ▲ +100.5% |
| 2014 | -0.60x | GBX-52.25 Million | GBX86.43 Million | ▼ -4091.8% |
| 2013 | 0.02x | GBX1.15 Million | GBX76.21 Million | ▲ +239.9% |
| 2012 | -0.01x | GBX-439.00K | GBX40.55 Million | — |